Given the crucial and diverse roles of tumor-infiltrating T cell subtypes in immunotherapy, we classified T cells into 10 subsets based on canonical makers, including seven CD8+, two CD4+, and one double-negative (CD4−CD8−) T cell subtypes (Fig. 2a and Supplementary Fig. 3a). The gene discussed is CD8A; the disease is neoplasm.